Soluble complement receptor 1 (CD35) bound to immune complexes in sera of patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 52, Issue 9, 2005, Pages 2950-2951

  Csipo, Istvan ^a   Kiss, Emese ^a   Bako, Eva ^a   Szegedi, Gyula ^b   Kavai, Maria ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Academy of Sciences   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CELL MEMBRANE PROTEIN; COMPLEMENT COMPONENT C3B RECEPTOR; EPITOPE;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; COMPLEMENT DEPOSITION; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SECRETION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULIN G; LUPUS NEPHRITIS; MICE; PROTEIN BINDING; RECEPTORS, COMPLEMENT 3B;

EID: 25444446809     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21245     Document Type: Article

References (11)

1. Taylor RP, Horgan C, Buschbacher R, Brunner CM, Hess CE, O'Brien WM, et al. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum 1983;26:736-44.
2. Kiss E, Csipo I, Cohen JH, Reveil B, Kavai M, Szegedi G. CR1 density polymorphism and expression on erythrocytes of patients with systemic lupus erythematosus. Autoimmunity 1996;25:53-8.
3. Miot S, Marfurt J, Lach-Trifilieff E, Gonzalez-Rubio C, Lopez-Trascasa M, Sadallah S, et al. The mechanism of loss of CR1 during maturation of erythrocytes is different between factor I deficient patients and healthy donors. Blood Cells Mol Dis 2002;29:200-12.
4. Pascual M, Duchosal MA, Steiger G, Giostra E, Pechere A, Paccaud JP, et al. Circulating soluble CR1 (CD35): serum levels in diseases and evidence for its release by human leukocytes. J Immunol 1993;151:1702-11.
5. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
6. Cohen JH, Atkinson JP, Klickstein LB, Oudin S, Subramanian VB, Moulds JM. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphism. Mol Immunol 1999;36:819-25.
7. Nardin A, Lindorfer NA, Taylor RP. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? Mol Immunol 1999;36:827-35.
8. Craig ML, Waitumbi JN, Taylor RP. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1. J Immunol 2005;174:3059-66.
9. Kiss E, Kavai M, Csipo I, Szegedi G. Recombinant human erythropoietin modulates erythrocyte complement receptor 1 functional activity in patients with lupus nephritis. Clin Nephrol 1998;49:364-9.
10. Csipo I, Kiss E, Soltesz P, Antal-Szalmas P, Szegedi G, Cohen JH, et al. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type 1 (CR1) of patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999;118:458-64.
11. Sadallah S, Hess C, Trendelenburg M, Vedeler C, Lopez-Trascasa M, Schifferli JA. Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clin Exp Immunol 2003;131:174-81.